New combo therapy targets returning prostate cancer and hidden spread
Disease control
Completed
This study tested a new approach for men whose prostate cancer came back after initial radiation treatment. It combined a local treatment (brachytherapy) with a targeted radioactive drug (177Lu-PSMA) to attack cancer cells both in the prostate and elsewhere in the body. Only 3 me…
Phase: PHASE1, PHASE2 • Sponsor: Glenn Bauman • Aim: Disease control
Last updated May 08, 2026 12:03 UTC